First Trust NYSE Arca Biotechnology Index Fund Rating → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free FBT Stock Alerts $143.65 +1.06 (+0.74%) (As of 04/26/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings First Trust NYSE Arca Biotechnology Index Fund Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FBT Aggregate RatingModerate Buy2.61Holdings in FBT have an aggregate rating of Moderate Buy based on 417 analyst ratings issued in the past year covering 30 companies (99.9% of the portfolio).FBT Aggregate Price Target$191.6633.42% UpsideHigh Prediction$260.42Average Prediction$191.66Low Prediction$142.18Holdings in FBT have an aggregate price target of $191.66 and a range of $142.18 to $260.42 covering 30 companies (99.9% of the portfolio).FBT Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust NYSE Arca Biotechnology Index Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 30 FBT Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.14%NTRANatera$91.66+0.4%2 of 5 stars3.00$86.40 -5.7%14Analyst DowngradeInsider Selling3.96%BRKRBruker$80.97+0.5%5 of 5 stars2.43$84.86 4.8%7Upcoming EarningsNews Coverage3.94%HALOHalozyme Therapeutics$38.57+0.3%5 of 5 stars2.86$53.29 38.2%7Analyst RevisionNews CoveragePositive News3.89%ITCIIntra-Cellular Therapies$73.26+1.6%4 of 5 stars2.90$90.17 23.1%10Upcoming EarningsAnalyst ReportAnalyst Revision3.88%UTHRUnited Therapeutics$233.85-0.9%5 of 5 stars2.89$294.25 25.8%9Upcoming EarningsInsider Selling3.62%MTDMettler-Toledo International$1,238.09+0.4%3 of 5 stars2.17$1,233.25 -0.4%6Positive News3.60%NBIXNeurocrine Biosciences$135.99-1.3%5 of 5 stars2.74$142.38 4.7%23Upcoming EarningsAnalyst ReportShort Interest ↓Analyst RevisionNews Coverage3.56%EXELExelixis$23.70+0.7%5 of 5 stars2.60$26.29 10.9%15Upcoming EarningsShort Interest ↑Analyst RevisionNews Coverage3.51%CORTCorcept Therapeutics$22.80+2.7%5 of 5 stars3.00$39.30 72.4%4Upcoming EarningsAnalyst Report3.46%MRNAModerna$107.97+1.7%4 of 5 stars2.25$126.49 17.1%16Upcoming EarningsInsider Selling3.46%BMRNBioMarin Pharmaceutical$80.91-1.5%5 of 5 stars2.63$107.50 32.9%19Analyst ReportOptions VolumeNews Coverage3.44%ARGXargenx$372.80+1.1%3 of 5 stars2.71$528.16 41.7%21Upcoming EarningsShort Interest ↑3.44%REGNRegeneron Pharmaceuticals$883.20-0.8%4 of 5 stars2.70$977.77 10.7%20Upcoming EarningsAnalyst ReportAnalyst RevisionNews Coverage3.43%WATWaters$311.30+1.0%2 of 5 stars1.88$298.67 -4.1%8Gap Up3.39%EXASExact Sciences$58.85+0.1%4 of 5 stars2.86$97.44 65.6%14Short Interest ↑Positive News3.26%VRTXVertex Pharmaceuticals$397.48-0.1%4 of 5 stars2.48$429.45 8.0%233.25%RGENRepligen$166.58+0.6%4 of 5 stars2.89$196.70 18.1%9Upcoming Earnings3.24%PTCTPTC Therapeutics$28.57+12.1%2 of 5 stars1.85$33.53 17.4%13Earnings ReportNews CoverageGap Up3.22%GMABGenmab A/S$28.15+2.5%3 of 5 stars2.38$48.50 72.3%13Short Interest ↑3.13%INSMInsmed$24.80-0.5%4 of 5 stars3.00$44.92 81.1%12Analyst ReportNews Coverage3.08%AMGNAmgen$269.98+0.2%5 of 5 stars2.53$296.95 10.0%19Upcoming Earnings3.03%ILMNIllumina$122.28+1.0%5 of 5 stars2.32$167.70 37.1%19Upcoming Earnings3.02%ALKSAlkermes$24.68+1.0%5 of 5 stars2.50$35.38 43.3%10Upcoming EarningsShort Interest ↓3.02%INCYIncyte$51.68+1.0%5 of 5 stars2.44$75.50 46.1%16Upcoming EarningsAnalyst ReportAnalyst Revision2.92%DVAXDynavax Technologies$11.21+0.4%4 of 5 stars2.75$25.00 123.0%4Analyst Downgrade2.76%BIIBBiogen$208.90+3.2%5 of 5 stars2.67$293.88 40.7%27Earnings ReportAnalyst ReportShort Interest ↓Analyst RevisionNews Coverage2.75%GILDGilead Sciences$65.42+0.2%5 of 5 stars2.31$84.50 29.2%17Earnings ReportAnalyst UpgradeOptions VolumeAnalyst RevisionNews Coverage2.70%BGNEBeiGene$153.58+3.4%3 of 5 stars2.80$250.13 62.9%10Upcoming EarningsAnalyst ReportShort Interest ↑News CoverageGap Up2.69%ALNYAlnylam Pharmaceuticals$143.31-0.3%5 of 5 stars2.59$215.88 50.6%17Upcoming EarningsShort Interest ↓News Coverage2.13%ACADACADIA Pharmaceuticals$16.71+2.5%4 of 5 stars2.80$35.82 114.4%15Analyst Revision This page (NYSEARCA:FBT) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology Index Fund Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
